Adamas Pharmaceuticals Inc. buy Quitte
Start price
23.12.15
/
50%
€20.62
Target price
06.01.16
€23.36
Performance (%)
12.12%
End price
06.01.16
€23.12
Summary
This prediction ended on 06.01.16 with a price of €23.12. The prediction had a final performance of 12.12%. Quitte has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Adamas Pharmaceuticals Inc. | - | - | - | - |
| iShares Core DAX® | 3.002% | 3.742% | 24.169% | 65.664% |
| iShares Nasdaq 100 | 2.966% | 1.308% | 9.141% | 111.170% |
| iShares Nikkei 225® | 5.606% | 4.472% | 21.237% | 55.883% |
| iShares S&P 500 | 2.312% | 1.880% | 6.333% | 67.956% |
Comments by Quitte for this prediction
In the thread Adamas Pharmaceuticals Inc. diskutieren
Erfolge bei Parkinson
Adamas Pharma: Phase-3-Studie zu ADS-5102 erzielt gewünschte Resultate
(Stop Loss Kurs erreicht)

